Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

435.00p
   
  • Change Today:
    -12.50p
  • 52 Week High: 485.00p
  • 52 Week Low: 325.00p
  • Currency: UK Pounds
  • Shares Issued: 47.49m
  • Volume: 32,309
  • Market Cap: £206.60m
  • RiskGrade: 180

Numis starts coverage of Tristel at 'add'

By Michele Maatouk

Date: Thursday 25 May 2023

LONDON (ShareCast) - (Sharecast News) - Numis started coverage of Tristel on Thursday with an 'add' rating and 390p price target.
It said Tristel is a unique play within UK Medtech, offering high-level disinfectants, backed by a proprietary chemistry, used for the decontamination of medical devices and surfaces in hospitals.

"We think Tristel could more than double revenue and profits over five years, with the base business underpinned by diagnostic procedure demand, while potential US market expansion, pending FDA approval, represents a significant growth inflection point, which we believe is partly discounted," it said.

Numis said that optically, its multiple - circa 15x EV/EBITDA - is not particularly cheap, but should growth catalysts materialise, "we could see outer year multiples unwind".

"With the FDA decision pending (Jun-23), we account for some US optionality, setting our target price at 390p, and initiate with an add rating."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 435.00p
Change Today -12.50p
% Change -2.79 %
52 Week High 485.00p
52 Week Low 325.00p
Volume 32,309
Shares Issued 47.49m
Market Cap £206.60m
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.09% below the market average97.09% below the market average97.09% below the market average97.09% below the market average97.09% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
Price Trend
73.37% above the market average73.37% above the market average73.37% above the market average73.37% above the market average73.37% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income
84.87% below the market average84.87% below the market average84.87% below the market average84.87% below the market average84.87% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
13.39% above the market average13.39% above the market average13.39% above the market average13.39% above the market average13.39% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Mar-24 23-Nov-23
Paid 12-Apr-24 22-Dec-23
Amount 5.24p 7.88p

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 5,000 @ 435.00p
16:35 4,967 @ 435.00p
16:35 33 @ 435.00p
15:06 682 @ 439.00p
15:05 1,000 @ 435.00p

Tristel Key Personnel

CEO Paul Christopher Swinney
Finance Director Elizabeth Dixon

Top of Page